Birth control has been a controversial issue in healthcare. “The pill” as it is commonly referred to as has been evolving over time causing extensive studies to be done. There has been birth control scares in the past causing fear and confusion which still continues to live on in the birth control world. False advertising and not fully disclosing the side effects of birth control pills has produced class action law suits in the past.
The most recent class action law suit dealing with birth control has been against Yaz and Yasmin which are considered to be”fourth-generation” oral contraceptives. Two studies done on Yaz and Yasmin suggested that it posed a higher risk of venous thromboembolism compared to other birth control pills in the market. Venous thromboembolism is rare condition on its own but is a life threatening condition defined as a blockage of an artery in the lungs by fat, air, blood clot, or tumor cells. Birth control pills increase the odds of getting a venous thromboembolism in women. The overall risk is one in every 2000 women who don’t take the pill, and nine to 10 per 10,000 for users. The Yaz birth control pill and Yasmin birth control pill has proven to be within the safe regulations.
However, the Society of Obstetricians and Gynaecologists of Canada has reported that the studies done are in fact false which means the pills carry the same risks as other birth control drugs on the market. The recent contradictory evidence and the subsequent media coverage has generated fear and confusion among its users. This has spawned a class action law suit which will further examine the drug. What doctors are worried about is the spread of confusion to all general oral contraceptives and drospirenone-containing oral contraceptives in particular. As principal author Dr. Robert Reid, a professor of obstetrics and gynecology at Queen’s University in Kingston says, “We were concerned that it was going to generate another pill scare like the ones we’ve seen in the past.”
A European surveillance study sponsored by Bayer Inc. supports what doctors have been saying along. The study showed, “Nearly 60,000 new users of various birth control pills found no difference in blood clot rates between Yasmin and Yaz and other birth control pills on the market”. Dr. Reid believes that the pill’s estrogen dose is the primary cause for blood clots. The first birth control pills contained 150 micrograms of estrogen while now most pills contain 35 micrograms or less. Reid mentions, “The trade-off is that, as you lower the dose of estrogen, you start to get more spotting. Women get fed up with it and they become non-compliant — they stop using the pill and then they run a risk of getting pregnant, which has a much higher risk of blood clot than any pill”. Gynecologists are now warning that the scare can result in unwanted pregnancies and cause a domino effect amongst all birth control pills.
Birth Control Buzz is a service company that provides birth control prices, types of birth control(prescription required), health administrative services, and birth control statistics predominantly to US patients seeking to purchase pharmaceuticals on-line. For more information, call 1-866-868-8850 or visit http://www.birthcontrolbuzz.com/.

One example would be the advantages of the
Birth Control comes in many forms including
Hormonal contraceptives are defined as the
The lessons taught during sexual education in school are a very important part of a teen’s development as a young adult. However, a new government report has reported that only two thirds of all teens have been taught about
Many are finding the results of a recent study to be quite surprising. Researchers conducted a study on a group of women to see if text message reminders help women remember to take their
The
Hashsoft has released their myPill 1.0 application for the iPhone. The application not only helps women remember to take their daily pill, it can also be used to track the history of their
The U.S Food and Drug Administration have approved of ella, a new one-dose emergency contraceptive that works longer than the current leading drug on the market. In June this year, the FDA unanimously voted that the use of ella provided convincing data and sufficient information on its safety. ella was approved last year in Europe under the name ellaOne and is currently used in 22 countries.
The myth that a girl won’t get pregnant the first time that she has sex has been broken. Virgins are very commonly using condoms the first time they have sex. The use of condoms has risen significantly, especially in premarital sex and first-time couples. This is significant because 94% of women ages 15 to 44 have had premarital sex. According to the Centers for Disease Control and Prevention, the use of condoms has increased from 55 percent to 88 percent in less than 20 years.
A recently conducted study has found that 
Researchers in the University of North Carolina are pushing for further research into the new idea that an ultrasound can be used as a reversible contraceptive for men. The idea is that a blast of ultrasound to the testes may be able to stop sperm production for approximately six months. Once the sperm production has been stopped, all the sperm in the sperm reserves must be used up before this contraceptive method is effective.
